These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 19088341)
21. Pneumococcal immunization of hospitalized patients. Ordin D Med Health R I; 2003 Aug; 86(8):258-9. PubMed ID: 14587468 [No Abstract] [Full Text] [Related]
22. Licensure of a 13-valent pneumococcal conjugate vaccine (PCV13) and recommendations for use among children - Advisory Committee on Immunization Practices (ACIP), 2010. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2010 Mar; 59(9):258-61. PubMed ID: 20224542 [TBL] [Abstract][Full Text] [Related]
23. Influenza and pneumococcal vaccination in older veterans: results from the behavioral risk factor surveillance system. Chi RC; Reiber GE; Neuzil KM J Am Geriatr Soc; 2006 Feb; 54(2):217-23. PubMed ID: 16460371 [TBL] [Abstract][Full Text] [Related]
25. Cost-effectiveness of conjugate pneumococcal vaccination in Singapore: comparing estimates for 7-valent, 10-valent, and 13-valent vaccines. Tyo KR; Rosen MM; Zeng W; Yap M; Pwee KH; Ang LW; Shepard DS Vaccine; 2011 Sep; 29(38):6686-94. PubMed ID: 21745516 [TBL] [Abstract][Full Text] [Related]
26. Geographic variation in invasive pneumococcal disease following pneumococcal conjugate vaccine introduction in the United States. Rosen JB; Thomas AR; Lexau CA; Reingold A; Hadler JL; Harrison LH; Bennett NM; Schaffner W; Farley MM; Beall BW; Moore MR; Clin Infect Dis; 2011 Jul; 53(2):137-43. PubMed ID: 21690620 [TBL] [Abstract][Full Text] [Related]
27. Bug Breakfast in the Bulletin: invasive pneumococcal disease. Gunaratnam PJ; Gilmour RE; Lowbridge C; McIntyre PB N S W Public Health Bull; 2013 Dec; 24(3):142. PubMed ID: 24360214 [No Abstract] [Full Text] [Related]
32. Concomitant administration of pneumococcal-23 and zoster vaccines provides adequate herpes zoster coverage. Wyman MJ; Stabi KL Ann Pharmacother; 2013; 47(7-8):1064-8. PubMed ID: 23715069 [TBL] [Abstract][Full Text] [Related]
33. Streptococcus pneumoniae: description of the pathogen, disease epidemiology, treatment, and prevention. Bridy-Pappas AE; Margolis MB; Center KJ; Isaacman DJ Pharmacotherapy; 2005 Sep; 25(9):1193-212. PubMed ID: 16164394 [TBL] [Abstract][Full Text] [Related]
34. Streptococcus pneumoniae colonization among patients with human immunodeficiency virus-1 who had received 23-valent polysaccharide pneumococcal vaccine. Lo YC; Lauderdale TL; Chang SY; Hsiao CF; Hung CC; Chang SC J Microbiol Immunol Infect; 2009 Jun; 42(3):234-42. PubMed ID: 19812857 [TBL] [Abstract][Full Text] [Related]
35. Invasive pneumococcal disease in western Sydney, 2002-2010. Flego KL; Truman G; Sheppeard V; Gilmour RE N S W Public Health Bull; 2011 Dec; 22(11-12):219-21. PubMed ID: 22243636 [No Abstract] [Full Text] [Related]
36. Invasive pneumococcal disease in Australia 2007 and 2008. Barry C; Krause VL; Cook HM; Menzies RI Commun Dis Intell Q Rep; 2012 Jun; 36(2):E151-65. PubMed ID: 23186214 [TBL] [Abstract][Full Text] [Related]
37. Use of Pneumococcal Disease Epidemiology to Set Policy and Prevent Disease during 20 Years of the Emerging Infections Program. Moore MR; Whitney CG Emerg Infect Dis; 2015 Sep; 21(9):1551-6. PubMed ID: 26291238 [TBL] [Abstract][Full Text] [Related]
38. Pneumococcal polysaccharide vaccine. Recommendation of the Immunization Practices Advisory Committee. Ann Intern Med; 1982 Feb; 96(2):203-5. PubMed ID: 6277218 [TBL] [Abstract][Full Text] [Related]